Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Clean Science & Technology Ltd

CLEAN
NSE
822.25
3.51%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Alert
Watchlist
Note

Clean Science & Technology Ltd

CLEAN
NSE
822.25
3.51%
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
8,739Cr
Close
Close Price
822.25
Industry
Industry
Speciality Chemicals
PE
Price To Earnings
35.60
PS
Price To Sales
9.00
Revenue
Revenue
971Cr
Rev Gr TTM
Revenue Growth TTM
4.35%
PAT Gr TTM
PAT Growth TTM
-5.81%
Peer Comparison
How does CLEAN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
CLEAN
VS

Quarterly Results

Upcoming Results on
14 May 2026
Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
217188181195228224238241264243245220
Growth YoY
Revenue Growth YoY%
6.0-19.6-26.8-18.04.919.131.523.715.98.42.8-8.8
Expenses
ExpensesCr
112112106108133129148142159143158147
Operating Profit
Operating ProfitCr
105767587959590991051008772
OPM
OPM%
48.540.541.344.541.542.337.740.939.741.135.632.9
Other Income
Other IncomeCr
13136814101151213710
Interest Expense
Interest ExpenseCr
000010000000
Depreciation
DepreciationCr
101111111316181817191919
PBT
PBTCr
10879698395898385100957563
Tax
TaxCr
272017202523242025241917
PAT
PATCr
815952637066596674705546
Growth YoY
PAT Growth YoY%
29.1-6.3-23.2-25.3-12.711.912.64.85.46.3-5.7-30.1
NPM
NPM%
37.131.328.832.230.929.424.727.328.128.922.620.9
EPS
EPS
7.65.54.95.96.66.25.56.27.06.65.24.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
241393419512685936791967971
Growth
Revenue Growth%
63.16.622.233.736.6-15.422.10.5
Expenses
ExpensesCr
168257234253385534459579607
Operating Profit
Operating ProfitCr
73136185259300402332388364
OPM
OPM%
30.434.744.250.543.843.042.040.137.5
Other Income
Other IncomeCr
51111263030413942
Interest Expense
Interest ExpenseCr
000000100
Depreciation
DepreciationCr
81114172536466974
PBT
PBTCr
70137182267305396327357332
Tax
TaxCr
2139436976100829286
PAT
PATCr
4998140198229295244264245
Growth
PAT Growth%
99.743.042.115.229.2-17.38.3-7.2
NPM
NPM%
20.324.833.338.733.431.530.827.425.3
EPS
EPS
4.69.213.218.721.527.823.024.923.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
111111111111111
Reserves
ReservesCr
1862713415297589991,1931,4061,489
Current Liabilities
Current LiabilitiesCr
384177102135116161156150
Non Current Liabilities
Non Current LiabilitiesCr
101411182126353635
Total Liabilities
Total LiabilitiesCr
2363274306609251,1521,3991,6081,684
Current Assets
Current AssetsCr
125193257395570630660799804
Non Current Assets
Non Current AssetsCr
111135173265354521739809880
Total Assets
Total AssetsCr
2363274306609251,1521,3991,6081,684

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
4585160193127279236214
Investing Cash Flow
Investing Cash FlowCr
-18-95-106-187-79-270-185-152
Financing Cash Flow
Financing Cash FlowCr
-5-11-55-60-55-53-53
Net Cash Flow
Net Cash FlowCr
22-21-2049-45-210
Free Cash Flow
Free Cash FlowCr
1346110109-12961072
CFO To PAT
CFO To PAT%
92.086.8114.797.255.794.696.980.9
CFO To EBITDA
CFO To EBITDA%
61.362.286.474.542.469.571.255.2

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
000021,17013,43214,11112,404
Price To Earnings
Price To Earnings
0.00.00.00.092.745.557.846.9
Price To Sales
Price To Sales
0.00.00.00.030.914.317.812.8
Price To Book
Price To Book
0.00.00.00.027.613.311.78.8
EV To EBITDA
EV To EBITDA
-0.4-0.10.0-0.170.333.442.531.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
53.056.569.275.967.265.265.063.7
OPM
OPM%
30.434.744.250.543.843.042.040.1
NPM
NPM%
20.324.833.338.733.431.530.827.4
ROCE
ROCE%
37.449.752.949.539.739.127.225.2
ROE
ROE%
26.035.940.836.829.729.220.318.7
ROA
ROA%
20.729.832.530.124.725.617.416.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Company Overview** **Clean Science & Technology Limited (CSTL)** is a leading Indian specialty and fine chemical manufacturer established in 2003, headquartered in Pune, Maharashtra. The company operates as a B2B global supplier with a strong focus on **green chemistry, catalytic innovation, and atom-efficient processes**. CSTL is recognized as one of the world’s largest producers of several key specialty chemicals, with an export footprint spanning **over 35 countries**, contributing more than **60–72% of total revenues from international markets**. CSTL serves three primary business segments: 1. **Performance Chemicals (67–70% of revenue)** 2. **Pharma & Agro Intermediates (19%)** 3. **FMCG Chemicals (12%)** The company is led by Promoter-Executive Directors with deep expertise in catalytic and clean technologies, and it operates four manufacturing units within the MIDC Kurkumbh, Pune cluster, each equipped with **zero liquid discharge (ZLD)** systems, in-house R&D, and independent utilities for operational resilience. --- ### **Strategic Transformation: From Supplier to Co-Development Partner** CSTL is undergoing a strategic evolution from a **product-centric model to a customer co-creation and co-development partner**. Key initiatives include: - **Deployment of Technical Account Managers (TAMs)** in key regions to align commercial teams with R&D and accelerate customer onboarding. - **Establishment of an Application Laboratory** (commissioned in 2024–25) enabling polymer, masterbatch, and coatings customers to test HALS products under real-world conditions — reducing validation timelines and enhancing customer confidence. - **Hybrid Go-to-Market Model**: Combines direct global engagement with select distributors to balance market reach and responsiveness. - Emphasis on **technical support**, including formulation assistance, regulatory guidance, and application testing, to deepen strategic customer relationships beyond transactional sales. --- ### **Core Strengths & Differentiation** #### 1. **Green Chemistry & Sustainable Manufacturing** CSTL is a pioneer in **eco-friendly, catalytic-based chemical synthesis**: - Operates all plants as **Zero Liquid Discharge (ZLD)** facilities, using advanced aerobic and anaerobic effluent systems. - Developed the **only commercial vapor-phase process globally** for manufacturing **Anisole from Phenol**, which produces only water as a byproduct — a breakthrough in waste prevention. - Proprietary **in-house catalysts** reduce dependence on toxic reagents, lower effluent generation, and improve atom economy and yield. - Solvent recovery and closed-loop processes minimize environmental impact and operating costs. #### 2. **R&D-Led Innovation & Pipeline** - Employs **~90 scientists**, including **9 PhDs**, across **four dedicated 24x7 R&D labs** and a state-of-the-art **pilot facility**. - R&D is **central to strategy**, not a support function, focused on: - Green chemistry - Atom economy - Catalytic efficiency - Rapid scale-up - Maintains a **continuous pipeline of 10+ new molecules** in development across performance chemicals, pharma, and FMCG. - In FY2024–25, achieved the **highest number of new product launches in its history**, including the full HALS series and DHDT. #### 3. **Backward Integration & In-House Process Expertise** - Fully backward integrated into key raw materials like **Anisole (world’s largest producer)**, **phenol, methanol**, and other intermediates. - Operates proprietary catalytic systems using technologies such as: - Vapour-phase reactions - Continuous flow reactors - Hydrogenation - Triphasic ring formation - Chlorination - Esterification and hydroamination --- ### **Key Product Milestones & Portfolio Expansion (2024–2026)** | Product / Segment | Key Highlights | |------------------|----------------| | **HALS (Hindered Amine Light Stabilizers)** | - Became the **first Indian company** and **fifth globally** to achieve **full backward integration** and commercial scale in the complete HALS series.<br>- Commercialized 5 grades: **770, 622, 944, 119, 2020**.<br>- Scaled up production using advanced catalytic methods, reducing input intensity and complexity.<br>- REACH-certified, exported to US, Europe, Turkey, Southeast Asia, and China.<br>- India currently imports ~3,000 tons/year of HALS; CSTL targets rapid domestic market capture with competitive pricing and just-in-time delivery. | | **DHDT (2,5-Dihydroxy-1,4-Dithiane)** | - Critical **pharmaceutical intermediate** for antiretroviral APIs.<br>- Developed via proprietary **chlorination chemistry** as an export-substituted product.<br>- Production commenced December 2024 at **Clean Fino-Chem Limited (CFCL)**.<br>- Enhances CSTL’s presence in regulated global pharma markets.<br>- Supports **India’s Aatmanirbhar Bharat initiative**. | | **Performance Chemicals** | - Flagship products: **MEHQ (world’s largest producer)**, **BHA**, **TBHQ**, **Ascorbyl Palmitate (AP)**, **4-MAP**, **Guaiacol**, **Veratrole**, **Anisole**.<br>- Expanding into **UV stabilizers, antioxidants, and polymer additives**.<br>- 4-MAP and Anisole: both ranked **#1 global suppliers**; used in sunscreens, perfumes, and pharma. | | **Pharma & Agro Intermediates** | - Key products: **DCC (sulphur-free, globally unique)**, **Guaiacol**, **Veratrole**, **DHDT**, **Barbituric Acid (repurposed PBQ plant)**.<br>- CSTL is **No. 1 in India** and **No. 2 globally** in DCC and Guaiacol production. | --- ### **Clean Fino-Chem Limited (CFCL) – Growth Engine** - **Wholly-owned greenfield subsidiary** established on a **34-acre site** in Kurkumbh. - **India’s largest dedicated HALS production facility**, representing CSTL’s biggest CAPEX project to date (investment of **₹3,851 million** funded via internal accruals). - **Concessional tax rate of 17.16%** (vs. standard 25.17%), enhancing ROI and future project attractiveness. - Hosts **India’s first end-to-end HALS manufacturing infrastructure** with full backward integration. - **Operational since March 2021**; commercialized **DHDT and multiple HALS grades**. - **Expected to operate at full design capacity in FY2025–26**, with phased launch of new products. - **On-site Application Lab** supports customer validation and co-innovation. - **Planned INR 300 crore expansion (FY2025–26)** for high-growth performance chemicals, leveraging CFCL’s modular infrastructure. --- ### **Market Position & Financial Highlights (FY2024–2025)** - **Record Consolidated Revenue**: **INR 950 Crores** in FY2025. - **Over 25% of revenue from new products** (HALS, DHDT, BHT, Performance Chemicals 1 & 2). - **EBITDA Margin**: ~41%, reflecting strong cost control and operational efficiency. - **Exports**: >60% of revenue, with major markets being **China (34%)**, **Americas & Europe (16% each)**, **India (28%)**, and rest of world. - **HALS sales volume grew 3.3x YoY** to **over 1,900 tons** in FY2025. - **Customer Base**: Over **500 global and domestic clients**. --- ### **Competitive Landscape & Strategy** - **Primary HALS Competitor**: **Unitechem (Suqian, China)**. Rianlon less of a threat. - **Differentiation**: - Proprietary green processes - Cost-efficient domestic manufacturing - Full backward integration - Customer-centric innovation - **Local Advantage vs. Imports**: Offers **2.5–3% price discount** vs. imported HALS + **just-in-time delivery** and no container shipment constraints. - **No new Chinese entrants** currently due to weak demand in their export markets. --- ### **Corporate Responsibility & Sustainability** - **Eco-Initiatives**: Zero liquid discharge, solvent recovery, waste minimization via atom economy. - **Environmental Recognition**: Silver GreenCo certified — **only Indian specialty chemical company** with this distinction. - Plans to **plant 11,000 trees** in coming years. - Compliance with ESG standards in global procurement processes.